{"id":210332,"date":"2017-02-23T04:46:20","date_gmt":"2017-02-23T09:46:20","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/why-sparks-ceo-says-2017-may-be-a-historic-year-for-his-gene-therapy-company-philadelphia-business-journal.php"},"modified":"2017-02-23T04:46:20","modified_gmt":"2017-02-23T09:46:20","slug":"why-sparks-ceo-says-2017-may-be-a-historic-year-for-his-gene-therapy-company-philadelphia-business-journal","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/why-sparks-ceo-says-2017-may-be-a-historic-year-for-his-gene-therapy-company-philadelphia-business-journal.php","title":{"rendered":"Why Spark&#8217;s CEO says 2017 may be a &#8216;historic year&#8217; for his gene therapy company &#8211; Philadelphia Business Journal"},"content":{"rendered":"<table border=\"0\" cellpadding=\"2\" cellspacing=\"7\" style=\"vertical-align:top;\"><tr><td width=\"80\" align=\"center\" valign=\"top\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGEHLgKemw-w1xbKPBpC7z-wbM9jw&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779393623241&amp;ei=Va-uWIiUMNfJ3gGD5K2oCA&amp;url=http:\/\/www.bizjournals.com\/philadelphia\/news\/2017\/02\/22\/spark-therapeutics-gene-therapy-final-stages-once.html\"><img loading=\"lazy\" decoding=\"async\" src=\"\/\/t3.gstatic.com\/images?q=tbn:ANd9GcS_ZaIbnNS4XC8Mql51bJtmmWgKsRFJ7UCc4BYbN4prbQVm-akTdsZgO7fzkvvL5TGOUp1ZIVJq\" alt=\"\" border=\"1\" width=\"80\" height=\"80\" style=\"padding-left:10px; padding-right: 10px;\"><br><font size=\"-2\">Philadelphia Business Journal<\/font><\/a><\/font><\/td><td valign=\"top\" class=\"j\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><div style=\"padding-top:0.8em;\"><img alt=\"\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\"><\/div><div class=\"lh\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGEHLgKemw-w1xbKPBpC7z-wbM9jw&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779393623241&amp;ei=Va-uWIiUMNfJ3gGD5K2oCA&amp;url=http:\/\/www.bizjournals.com\/philadelphia\/news\/2017\/02\/22\/spark-therapeutics-gene-therapy-final-stages-once.html\"><b>Why Spark's CEO says 2017 may be a 'historic year' for his <b>gene therapy<\/b> company<\/b><\/a><br><font size=\"-1\"><b><font color=\"#6f6f6f\">Philadelphia Business Journal<\/font><\/b><\/font><br><font size=\"-1\">Philadelphia <b>gene therapy<\/b> company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children <b>...<\/b><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNFNjf6ozlTR-205P8deNykqqimVdw&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779393623241&amp;ei=Va-uWIiUMNfJ3gGD5K2oCA&amp;url=https:\/\/globenewswire.com\/news-release\/2017\/02\/22\/926314\/0\/en\/Spark-Therapeutics-Reports-2016-Financial-Results-and-Business-Highlights.html\">Spark Therapeutics Reports 2016 Financial Results and Business Highlights<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>GlobeNewswire (press release)<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNHGw7_TkFXD-zaGIm7bZ2-6c444Mg&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779393623241&amp;ei=Va-uWIiUMNfJ3gGD5K2oCA&amp;url=https:\/\/www.equities.com\/news\/spark-therapeutics-inc-once-plunges-5-15-on-february-22\">Spark Therapeutics Inc. (ONCE) Plunges 5.15% on February 22<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Equities.com<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNHc13_zfOJCqdamQvCAo6PTMLJsXQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779393623241&amp;ei=Va-uWIiUMNfJ3gGD5K2oCA&amp;url=http:\/\/seekingalpha.com\/article\/4048453-spark-therapeutics-inc-s-ceo-jeffrey-marrazzo-q4-2016-results-earnings-call-transcript\">Spark Therapeutics, Inc.'s (ONCE) CEO Jeffrey Marrazzo on Q4 2016 Results - Earnings Call Transcript<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Seeking Alpha<\/nobr><\/font><\/font><br><font size=\"-1\" class=\"p\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNFK9zqrHnyJtrH52iekI3j0g5_IRw&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779393623241&amp;ei=Va-uWIiUMNfJ3gGD5K2oCA&amp;url=https:\/\/www.highlandmirror.com\/2017-02-22-spark-therapeutics-inc-once-releases-earnings-results-misses-expectations-by-0-11-eps\"><nobr>Highland Mirror<\/nobr><\/a>&nbsp;-<a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNG-IsANrDo40FCq92HvNnn2lPturg&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779393623241&amp;ei=Va-uWIiUMNfJ3gGD5K2oCA&amp;url=https:\/\/www.thecerbatgem.com\/2017\/02\/23\/spark-therapeutics-inc-once-rating-increased-to-strong-buy-at-vetr-inc.html\"><nobr>The Cerbat Gem<\/nobr><\/a><\/font><br><font class=\"p\" size=\"-1\"><a class=\"p\" href=\"http:\/\/news.google.com\/news\/more?ncl=dU03eNN-IwLOSwMDRUVHnKHCgtgBM&amp;authuser=0&amp;ned=us\"><nobr><b>all 22 news articles&nbsp;&raquo;<\/b><\/nobr><\/a><\/font><\/div><p><\/p><\/font><\/td><\/tr><\/table><p><!-- Auto Generated --><\/p><p>Read this article: <\/p><p><a target=\"_blank\" href=\"http:\/\/www.bizjournals.com\/philadelphia\/news\/2017\/02\/22\/spark-therapeutics-gene-therapy-final-stages-once.html\" title=\"Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company - Philadelphia Business Journal\">Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company - Philadelphia Business Journal<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p> Philadelphia Business Journal Why Spark&#39;s CEO says 2017 may be a &#39;historic year&#39; for his gene therapy company Philadelphia Business Journal Philadelphia gene therapy company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children ... Spark Therapeutics Reports 2016 Financial Results and Business Highlights GlobeNewswire (press release) Spark Therapeutics Inc. (ONCE) Plunges 5.15% on February 22 Equities.com Spark Therapeutics, Inc.&#39;s (ONCE) CEO Jeffrey Marrazzo on Q4 2016 Results - Earnings Call Transcript Seeking Alpha Highland Mirror &nbsp;- The Cerbat Gem all 22 news articles&nbsp;&raquo;  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/why-sparks-ceo-says-2017-may-be-a-historic-year-for-his-gene-therapy-company-philadelphia-business-journal.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-210332","post","type-post","status-publish","format-standard","hentry","category-gene-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/210332"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=210332"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/210332\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=210332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=210332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=210332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}